GGrantIndex
← Leaderboards

Ronald Sherwin Swerdloff

La Biomed Res Inst/ Harbor Ucla Med Ctr

$7,352,119
Attributed
$7,352,119
Total exposure
32
Grants
19
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.2M · FY200524
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$7,352,119 · 32

By mechanism

M01$3,638,922 · 28
T32$2,120,821 · 1
P50$1,592,376 · 2
N01$0 · 1

Top collaborators

No co-investigators on record.

Most similar at La Biomed Res Inst/ Harbor Ucla Med Ctr

Same institution · by research overlap

Others in their field

Top investigators on “Male

Research focus

MaleClinical ResearchHuman SubjectTestosteroneHypogonadismGrantResearch PersonnelHormone TherapyHuman Therapy EvaluationFundingInstitutionSourceResourcesComputer Retrieval Of Information On Scientific Projects DatabaseUnited States National Institutes Of HealthHormonesClinical TrialsPharmaceutical PreparationsRandomizedAdultBloodAndrogensDoseDrug Screening /Evaluation

Grant awards (68)

Diet and Exercise Modulate the Sperm Epigenome in Men$305,257
P50 · FY2024 · HD · contact PI
Diet and Exercise Modulate the Sperm Epigenome in Men$308,338
P50 · FY2023 · HD · contact PI
Diet and Exercise Modulate the Sperm Epigenome in Men$308,207
P50 · FY2022 · HD · contact PI
Diet and Exercise Modulate the Sperm Epigenome in Men$308,024
P50 · FY2020 · HD · contact PI
Diet and Exercise Modulate the Sperm Epigenome in Men$362,550
P50 · FY2019 · HD · contact PI
Endocrinology, Metabolism and Nutrition Training Grant$197,415
T32 · FY2013 · DK · contact PI
Endocrinology, Metabolism and Nutrition Training Grant$194,292
T32 · FY2012 · DK · contact PI
Endocrinology, Metabolism and Nutrition Training Grant$133,448
T32 · FY2011 · DK · contact PI
Endocrinology, Metabolism and Nutrition Training Grant$32,184
T32 · FY2011 · DK · contact PI
PHASE II STUDY OF THE EFFECT OF FOOD WITH VARIOUS LEVELS OF FAT ON THE PHARMACOK$210,105
M01 · FY2010 · RR · contact PI
Endocrinology, Metabolism and Nutrition Training Grant$197,409
T32 · FY2010 · DK · contact PI
A PHASE I, RANDOMIZED, OPEN-LABEL, CROSS-OVER STUDY TO INVESTIGATE POTENTIAL$358,337
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: PHASE IIA, REPEAT DOSE, PHARMACOKINETIC STUDY OF ORAL TESTOSTERO$276,432
M01 · FY2009 · RR · contact PI
PHASE IIA, PILOT, PHARMACOKINETIC STUDY OF ORAL TESTOSTERONE ESTER FORMULATIO$219,657
M01 · FY2009 · RR · contact PI
Endocrinology, Metabolism and Nutrition Training Grant$198,251
T32 · FY2009 · DK · contact PI
A PHASE III OPEN-LABEL STUDY OF THE EFFICACY AND SAFETY OF ARD-0403$131,235
M01 · FY2009 · RR · contact PI
A PHASE III, RANDOMIZED, MULTI-CENTER, OPEN-LABEL, FOLLOW-ON STUDY FOR LONG T$5,584
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: A PHASE I, RANDOMIZED, OPEN-LABEL, CROSS-OVER STUDY TO INVESTIGA$182,739
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: PHASE I, PILOT, PHARMACOKINETIC STUDY OF AN ORAL TESTOSTERONE PA$155,694
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: A PHASE III OPEN-LABEL STUDY OF THE EFFICACY AND SAFETY OF ARD-0$96,487
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: A PHASE II, PLACEBO-CONTROLLED, DOUBLE-BLIND, DOSE-RANGING (35MG$730
M01 · FY2008 · RR · contact PI
PHASE I, PILOT, PHARMACOKINETIC STUDY OF AN ORAL TESTOSTERONE PALMITATE FORMU$189,728
M01 · FY2007 · RR · contact PI
Endocrinology, Metabolism and Nutrition Training Grant$179,849
T32 · FY2007 · DK · contact PI
A PHASE II, PLACEBO-CONTROLLED, DOUBLE-BLIND, DOSE-RANGING (35MG/D OR 70MG/D)$14,401
M01 · FY2007 · RR · contact PI
Endocrinology, Metabolism and Nutrition Training Grant$179,849
T32 · FY2006 · DK · contact PI
A PHASE II, PLACEBO-CONTROLLED, DOUBLE-BLIND, DOSE-RANGING (35MG/D OR 70MG/D)$148,348
M01 · FY2006 · RR · contact PI
PHASE I, PILOT, PHARMACOKINETIC STUDY OF AN ORAL TESTOSTERONE PALMITATE FORMU$136,506
M01 · FY2006 · RR · contact PI
TESTOSTERONE TREATMENT FOR MULTIPLE SCLEROSIS: A PRELIMINARY TRIAL$18,077
M01 · FY2006 · RR · contact PI
NICHD CONTRACEPTIVE CLINICAL TRIALS NETWORK /MALE CONTRACEPTIVE TRIALS-275003369$0
N01 · FY2006 · HD · contact PI
Endocrinology, Metabolism and Nutrition Training Grant$171,632
T32 · FY2005 · DK
PILOT, PHASE I PHARMACOKINETIC STUDY OF THREE FORMULATIONS OF ORAL TESTOSTERO$137,441
M01 · FY2005 · RR
TESTOSTERONE TREATMENT FOR MULTIPLE SCLEROSIS: A PRELIMINARY TRIAL$69,351
M01 · FY2005 · RR
A PHASE II, PLACEBO-CONTROLLED, DOUBLE-BLIND, DOSE-RANGING (35MG/D OR 70MG/D)$24,588
M01 · FY2005 · RR
Endocrinology, Metabolism and Nutrition Training Grant$171,632
T32 · FY2004 · DK
Testosterone Treatment for Multiple Sclerosis: A Preliminary Trial$47,500
M01 · FY2004 · RR
Pharmacokinetic Evaluation of Testosterone-Gel (1%) in Prepubertal Boys of Ad...$21,182
M01 · FY2004 · RR
Endocrinology, Metabolism and Nutrition Training Grant$90,225
T32 · FY2003 · DK
ENDOCRINOLOGY, METABOLISM AND NUTRITION TRAINING GRANT$98,367
T32 · FY2002 · DK
GNRH AGONIST HIGH DOSE PROTOCOL$237,978
M01 · FY2001 · RR
DIHYDROTESTOSTERONE IN ELDERLY HYPOGONADAL MEN$237,978
M01 · FY2001 · RR
ETHNIC DIFFERENCES IN REPRODUCTION AXIS: APPLICATION TO HORMONAL MALE$237,978
M01 · FY2001 · RR
TESTOSTERONE GEL FOR HORMONAL REPLACEMENT IN HYPOGONADAL MEN$237,978
M01 · FY2001 · RR
COGNITIVE DYSFUNCTION IN KLINEFELTERS SYNDROME &OTHER SEX CHROMOSOME DISORDERS$237,978
M01 · FY2001 · RR
ENDOCRINOLOGY, METABOLISM AND NUTRITION TRAINING GRANT$143,607
T32 · FY2001 · DK
ENDOCRINOLOGY, METABOLISM AND NUTRITION TRAINING GRANT$132,661
T32 · FY2000 · DK
ETHNIC DIFFERENCES IN REPRODUCTION AXIS: APPLICATION TO HORMONAL MALE$982
M01 · FY2000 · RR
TESTOSTERONE GEL FOR HORMONAL REPLACEMENT IN HYPOGONADAL MEN$982
M01 · FY2000 · RR
COGNITIVE DYSFUNCTION IN KLINEFELTERS SYNDROME &OTHER SEX CHROMOSOME DISORDERS$982
M01 · FY2000 · RR
DIHYDROTESTOSTERONE IN ELDERLY HYPOGONADAL MEN$982
M01 · FY2000 · RR
GNRH AGONIST HIGH DOSE PROTOCOL$982
M01 · FY2000 · RR
Safety &effectiveness of dihydrotestosterone-gel for hormonal replacement in eld$0
M01 · FY2000 · RR
Safety &effectiveness of dihydrotestosterone-gel for hormonal replacement in eld$0
M01 · FY2000 · RR
Effect of GI 198745 on spermatogenesis on normal healthy male subjects$0
M01 · FY2000 · RR
Effect of GI 198745 on spermatogenesis on normal healthy male subjects$0
M01 · FY2000 · RR
Effect of GI 198745 on spermatogenesis on normal healthy male subjects$0
M01 · FY2000 · RR
Androgen ablation influence on comorbid disease in prostate cancer$0
M01 · FY2000 · RR
Androgen ablation influence on comorbid disease in prostate cancer$0
M01 · FY2000 · RR
Androgen ablation influence on comorbid disease in prostate cancer$0
M01 · FY2000 · RR
TESTOSTERONE GEL FOR HORMONAL REPLACEMENT IN HYPOGONADAL MEN$0
M01 · FY2000 · RR
TESTOSTERONE GEL FOR HORMONAL REPLACEMENT IN HYPOGONADAL MEN$0
M01 · FY2000 · RR
DIHYDROTESTOSTERONE IN ELDERLY HYPOGONADAL MEN$0
M01 · FY2000 · RR
COGNITIVE DYSFUNCTION IN KLINEFELTERS SYNDROME &OTHER SEX CHROMOSOME DISORDERS$0
M01 · FY2000 · RR
COGNITIVE DYSFUNCTION IN KLINEFELTERS SYNDROME &OTHER SEX CHROMOSOME DISORDERS$0
M01 · FY2000 · RR
DIHYDROTESTOSTERONE IN ELDERLY HYPOGONADAL MEN$0
M01 · FY2000 · RR
US study of semen quality in partners of pregnant women$0
M01 · FY2000 · RR
US study of semen quality in partners of pregnant women$0
M01 · FY2000 · RR
US study of semen quality in partners of pregnant women$0
M01 · FY2000 · RR
Safety &effectiveness of dihydrotestosterone-gel for hormonal replacement in eld$0
M01 · FY2000 · RR